DK2968606T3 - Behandling af autoimmune sygdomme - Google Patents

Behandling af autoimmune sygdomme Download PDF

Info

Publication number
DK2968606T3
DK2968606T3 DK14764420.7T DK14764420T DK2968606T3 DK 2968606 T3 DK2968606 T3 DK 2968606T3 DK 14764420 T DK14764420 T DK 14764420T DK 2968606 T3 DK2968606 T3 DK 2968606T3
Authority
DK
Denmark
Prior art keywords
autoimmunal
diseases
treatment
autoimmunal diseases
Prior art date
Application number
DK14764420.7T
Other languages
Danish (da)
English (en)
Inventor
Alan P Escher
Original Assignee
Univ Loma Linda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Loma Linda filed Critical Univ Loma Linda
Application granted granted Critical
Publication of DK2968606T3 publication Critical patent/DK2968606T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/106—Plasmid DNA for vertebrates
    • C12N2800/107—Plasmid DNA for vertebrates for mammalian
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/46—Vector systems having a special element relevant for transcription elements influencing chromatin structure, e.g. scaffold/matrix attachment region, methylation free island
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cosmetics (AREA)
DK14764420.7T 2013-03-15 2014-03-14 Behandling af autoimmune sygdomme DK2968606T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361800354P 2013-03-15 2013-03-15
PCT/US2014/029685 WO2014145042A1 (en) 2013-03-15 2014-03-14 Treatment of autoimmune diseases

Publications (1)

Publication Number Publication Date
DK2968606T3 true DK2968606T3 (da) 2020-10-26

Family

ID=51537869

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14764420.7T DK2968606T3 (da) 2013-03-15 2014-03-14 Behandling af autoimmune sygdomme

Country Status (8)

Country Link
EP (1) EP2968606B1 (cg-RX-API-DMAC7.html)
JP (3) JP6499155B2 (cg-RX-API-DMAC7.html)
CN (2) CN105451777A (cg-RX-API-DMAC7.html)
AU (2) AU2014233428B2 (cg-RX-API-DMAC7.html)
CA (1) CA2902565C (cg-RX-API-DMAC7.html)
DK (1) DK2968606T3 (cg-RX-API-DMAC7.html)
ES (1) ES2825078T3 (cg-RX-API-DMAC7.html)
WO (1) WO2014145042A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11680273B2 (en) 2011-09-23 2023-06-20 Loma Linda University Treatment of autoimmune diseases
WO2013044177A2 (en) 2011-09-23 2013-03-28 Loma Linda University Bacterial strains expressing methylase genes and uses thereof
CN105451777A (zh) * 2013-03-15 2016-03-30 洛马林达大学 自身免疫性疾病的治疗
US20180345047A1 (en) * 2015-02-26 2018-12-06 Yeda Research And Development Co. Ltd. Method of promoting hair growth

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
DE3223885A1 (de) 1982-06-26 1983-12-29 Basf Ag, 6700 Ludwigshafen Makroporoese, hydrophile traeger fuer enzyme
US4945050A (en) 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US5036006A (en) 1984-11-13 1991-07-30 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US5100792A (en) 1984-11-13 1992-03-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues
US4871488A (en) 1985-04-22 1989-10-03 Albany Medical College Of Union University Reconstituting viral glycoproteins into large phospholipid vesicles
US4663161A (en) 1985-04-22 1987-05-05 Mannino Raphael J Liposome methods and compositions
US5179022A (en) 1988-02-29 1993-01-12 E. I. Du Pont De Nemours & Co. Biolistic apparatus for delivering substances into cells and tissues in a non-lethal manner
US5693622A (en) 1989-03-21 1997-12-02 Vical Incorporated Expression of exogenous polynucleotide sequences cardiac muscle of a mammal
US6673776B1 (en) 1989-03-21 2004-01-06 Vical Incorporated Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human
US6214804B1 (en) 1989-03-21 2001-04-10 Vical Incorporated Induction of a protective immune response in a mammal by injecting a DNA sequence
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5225212A (en) 1989-10-20 1993-07-06 Liposome Technology, Inc. Microreservoir liposome composition and method
US5264618A (en) 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
US6132419A (en) 1992-05-22 2000-10-17 Genetronics, Inc. Electroporetic gene and drug therapy
US5395619A (en) 1993-03-03 1995-03-07 Liposome Technology, Inc. Lipid-polymer conjugates and liposomes
US5993434A (en) 1993-04-01 1999-11-30 Genetronics, Inc. Method of treatment using electroporation mediated delivery of drugs and genes
HUT75162A (en) 1993-11-16 1997-04-28 Depotech Corp Vesicles with controlled release of actives
US5549127A (en) 1995-05-03 1996-08-27 Chang; Wen-Hsiung Spring fixing structure for a hairgrip
US5763270A (en) 1995-06-07 1998-06-09 Genemedicine, Inc. Plasmid for delivery of nucleic acids to cells and methods of use
EP0914094A4 (en) 1996-03-28 2000-03-01 Univ Illinois MATERIALS AND METHOD FOR PRODUCING IMPROVED LIPOSOMAL AGENTS
US5851818A (en) 1996-05-31 1998-12-22 Sequus Pharmaceuticals, Inc. Condensed plasmid-liposome complex for transfection
US5827533A (en) 1997-02-06 1998-10-27 Duke University Liposomes containing active agents aggregated with lipid surfactants
US6233483B1 (en) 1997-05-14 2001-05-15 Pacesetter, Inc. System and method for generating a high efficiency biphasic defibrillation waveform for use in an implantable cardioverter/defibrillator (ICD).
US6200598B1 (en) 1998-06-18 2001-03-13 Duke University Temperature-sensitive liposomal formulation
US6800484B2 (en) 1998-06-24 2004-10-05 Genetronics, Inc. High efficiency transfection based on low electric field strength, long pulse length
WO2000045823A1 (en) 1999-02-08 2000-08-10 Chiron Corporation Electrically-mediated enhancement of dna vaccine immunity and efficacy in vivo
JP2008538716A (ja) * 2005-04-25 2008-11-06 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 超音波トランスデューサシステムにより連続撮像するための方法及び装置
US20090191218A1 (en) * 2005-05-11 2009-07-30 Fengchun Li DNA Vaccines And Methods For The Prevention Of Transplantation Rejection
WO2006124375A2 (en) * 2005-05-11 2006-11-23 Loma Linda University Substances, compositions and methods for preventing and treating immune-mediated inflammatory disorders
AU2009223148B2 (en) * 2008-03-12 2013-03-14 Loma Linda University DNA vaccines and methods for the prevention of transplantation rejection
WO2011109529A1 (en) 2010-03-03 2011-09-09 Zymo Research Corporation Detection of dna methylation
WO2013044177A2 (en) * 2011-09-23 2013-03-28 Loma Linda University Bacterial strains expressing methylase genes and uses thereof
CN105451777A (zh) * 2013-03-15 2016-03-30 洛马林达大学 自身免疫性疾病的治疗

Also Published As

Publication number Publication date
EP2968606A1 (en) 2016-01-20
CN105451777A (zh) 2016-03-30
JP2016516725A (ja) 2016-06-09
JP6499155B2 (ja) 2019-04-10
ES2825078T3 (es) 2021-05-14
JP2021091742A (ja) 2021-06-17
AU2014233428B2 (en) 2019-09-19
CA2902565A1 (en) 2014-09-18
AU2019219835A1 (en) 2019-09-12
EP2968606A4 (en) 2016-10-12
WO2014145042A1 (en) 2014-09-18
HK1220127A1 (en) 2017-04-28
CA2902565C (en) 2022-11-29
EP2968606B1 (en) 2020-10-07
AU2014233428A1 (en) 2015-09-17
CN110237270A (zh) 2019-09-17
JP2019077715A (ja) 2019-05-23
AU2019219835B2 (en) 2021-10-07

Similar Documents

Publication Publication Date Title
DK2968208T3 (da) Behandling af kataplexi
DK2981255T3 (da) Terapeutiske anvendelser af empagliflozin
DK3021838T3 (da) Behandling af fedme
DK3851537T3 (da) Behandling af hyperbilirubinæmi
DK3626270T3 (da) Behandling af kardiovaskulære sygdomme
HRP20190101T1 (hr) Terapeutske uporabe empagliflozina
DK2961388T3 (da) Kombinationer af lægemidler
PL3076967T3 (pl) Metody leczenia objawów rezydualnych schizofrenii
DK2970954T3 (da) Modifikation af polypeptider
HRP20180684T1 (hr) Kombinacija lijekova
LT3007726T (lt) Tautopatijos gydymo būdai
LT3312195T (lt) Nebaigtinės osteogenezės gydymo būdai
PT2953948T (pt) Antagonistas de integrina fluorada
EP2968867C0 (en) CATHETER ASSEMBLY
DK2961378T3 (da) Fremgangsmåder til behandlingen af mitochondrisk sygdom
DK2965026T3 (da) Generering af slushice
DK3470018T3 (da) Kryokonservering af levedygtige menneskehudssubstitutter
EP2988708A4 (en) ANKLE SUPPORT
DK3060226T3 (da) Fagterapi af pseudomonasinfektioner
DK3060908T3 (da) Diagnosticering og behandling af autoimmune sygdomme
EP2945942A4 (en) Voriconazole IMMUNOASSAY
DK3237621T5 (da) Varianter af human alpha-galactosidase
DK3024816T3 (da) Ppar-sparende forbindelser til behandling af metaboliske sygdomme
DK3297619T3 (da) Terapeutiske anvendelser af L-4-chlorkynurenin
EP2988738A4 (en) THERAPEUTIC INDICATIONS OF KINASE INHIBITORS